Glucose metabolism in triple-negative breast cancer cells (WP5211)
Homo sapiens
Glucose metabolism in triple-negative breast cancer cells. The glycolytic pathway is significantly upregulated in triple-negative breast tumors. The genes coding the key glycolytic enzymes are overexpressed in triple-negative breast tumors. TCA, tricarboxylic acid cycle; G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; F1,6P, fructose-1,6-bisphosphate; PEP, phosphoenolpyruvate; OAA, oxaloacetate; α-KG, α-ketoglutarate; GLUT, glucose transporter; HK, hexokinase; PFK, phosphofructokinase; PKM2, pyruvate kinase isozyme type 2; LDHA, lactate dehydrogenase A; MCT1, monocarboxylate transporter 1; PDK1, pyruvate dehydrogenase kinase 1; PDH, pyruvate dehydrogenase.
Authors
Andra Waagmeester , Egon Willighagen , Alex Pico , Martina Summer-Kutmon , and Eric WeitzActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
Annotations
Pathway Ontology
glycolysis pathway cancer pathway pentose phosphate pathway disease pathway citric acid cycle pathwayDisease Ontology
triple-receptor negative breast cancer breast cancerLabel | Type | Compact URI | Comment |
---|---|---|---|
Acetyl CoA | Metabolite | chebi:15351 | |
Lactate | Metabolite | chebi:16651 | |
NADPH | Metabolite | chebi:16474 | |
phosphoenolpyruvate | Metabolite | chebi:18021 | |
Fructose-6-phosphate | Metabolite | chebi:15946 | |
fructose-1,6-bisphosphate | Metabolite | chebi:78682 | |
Glucose | Metabolite | wikidata:Q37525 | |
Pyruvate | Metabolite | chebi:15361 | |
glucose-6-phosphate | Metabolite | wikidata:Q32778969 | |
pyruvate | Metabolite | chebi:15361 | |
PDK1 | GeneProduct | ensembl:ENSG00000152256 | |
HK | GeneProduct | ncbigene:3098 | |
PFKP | GeneProduct | ncbigene:5214 | |
GLUT1 | GeneProduct | ncbigene:6513 | |
LDHA | GeneProduct | ensembl:ENSG00000134333 | |
MCT1 | GeneProduct | ncbigene:6566 | |
PDH | GeneProduct | ncbigene:54704 | |
PKM2 | GeneProduct | ncbigene:5315 |
References
- Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Patra KC, Wang Q, Bhaskar PT, Miller L, Wang Z, Wheaton W, et al. Cancer Cell. 2013 Aug 12;24(2):213–28. PubMed Europe PMC Scholia
- High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis. Avanzato D, Pupo E, Ducano N, Isella C, Bertalot G, Luise C, et al. Cancer Res. 2018 Jul 1;78(13):3432–44. PubMed Europe PMC Scholia
- Metabolic Reprogramming in Triple-Negative Breast Cancer. Sun X, Wang M, Wang M, Yu X, Guo J, Sun T, et al. Front Oncol. 2020 Mar 31;10:428. PubMed Europe PMC Scholia